Stay informed with the latest updates for the inheritable blood disorders community.

          NBDF & Community
          DEI - Artwork of Diverse Group of People Men Women
          A Message from NHF President and CEO
          NBDF & Community
          NHF Wednesday Webinars 2021
          April 2021 Webinar Webinar Lineup
          Advocacy & Legislative
          How the American Rescue Plan Can Affect Your Healthcare Coverage
          How the American Rescue Plan Can Affect Your Healthcare Coverage
          Industry
          uniQure Announces Findings from HCC Case Investigation in HOPE-B Trial for Gene Therapy
          uniQure Announces Findings from HCC Case Investigation
          NBDF & Community
          NHF Letter to the Community
          Letter to the Community
          Industry
          Ampoule bottles on an assembly line
          Update to Hemlibra® (emicizumab-kxwh) USPI
          COVID-19
          Learn More About the COVID-19 Vaccines and ITP
          Learn More About the COVID-19 Vaccines and ITP
          NBDF & Community
          Keri L. Norris
          New Vice President of Health Equity, Diversity and Inclusion Joins NHF
          NBDF & Community
          NHF Announces Plans for 2021 NHF State of the Science Research Summit
          NHF Announces Plans for 2021 NHF State of the Science Research Summit
          Medical
          Newly Updated MASAC Documents Dedicated to Females Affected by Bleeding Disorders, Pregnancy, VWD
          Updated MASAC Documents Address Females Affected by Bleeding…
          NBDF & Community
          Nominations Open for the 2021 NHF Awards of Excellence
          NBDF & Community
          NHF
          A Refocused Mission for NHF Emphasizes Research
          Industry
          New Program Looks to Standardize Care for Patients with Rare Diseases
          New Program Looks to Standardize Care for Patients with Rare Diseases
          NBDF & Community
          NHF Wednesday Webinars 2021
          March 2021 Wednesday Webinar Schedule
          Industry
          FDA Partially Rescinds Added Indications for Two FIX Products